DTIL – Precision BioSciences, Inc.
Float Short %
12.03
Margin Of Safety %
Put/Call OI Ratio
EPS Next Q Diff
0.56
EPS Last/This Y
-9.22
EPS This/Next Y
1.49
Price
4.64
Target Price
30.5
Analyst Recom
1
Performance Q
-8.35
Relative Volume
1.39
Beta
1.69
Ticker: DTIL
20 items
«
‹
of 1
›
»
Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
---|---|---|---|---|---|
2025-08-15 | DTIL | 4.66 | N/A | N/A | 0 |
2025-08-18 | DTIL | 4.97 | N/A | N/A | 0 |
2025-08-19 | DTIL | 4.73 | N/A | N/A | 0 |
2025-08-20 | DTIL | 4.68 | N/A | N/A | 0 |
2025-08-21 | DTIL | 4.79 | N/A | N/A | 0 |
2025-08-22 | DTIL | 4.97 | N/A | N/A | 0 |
2025-08-25 | DTIL | 5.14 | N/A | N/A | 0 |
2025-08-26 | DTIL | 5.05 | N/A | N/A | 0 |
2025-08-27 | DTIL | 5.06 | N/A | N/A | 0 |
2025-08-28 | DTIL | 5.03 | N/A | N/A | 0 |
2025-08-29 | DTIL | 4.86 | N/A | N/A | 0 |
2025-09-02 | DTIL | 5.01 | N/A | N/A | 0 |
2025-09-03 | DTIL | 5.07 | N/A | N/A | 0 |
2025-09-04 | DTIL | 5.05 | N/A | N/A | 0 |
2025-09-05 | DTIL | 5.12 | N/A | N/A | 0 |
2025-09-08 | DTIL | 4.96 | N/A | N/A | 0 |
2025-09-09 | DTIL | 5.14 | N/A | N/A | 0 |
2025-09-10 | DTIL | 4.98 | N/A | N/A | 0 |
2025-09-11 | DTIL | 5.02 | N/A | N/A | 0 |
2025-09-12 | DTIL | 4.62 | N/A | N/A | 0 |
Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
20 items
«
‹
Current Page1 of 1
›
»
20 items
«
‹
of 1
›
»
Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
---|---|---|---|---|---|
2025-08-15 | DTIL | 4.71 | 0.4 | - | -8.17 |
2025-08-18 | DTIL | 4.97 | 1.8 | - | -8.17 |
2025-08-19 | DTIL | 4.80 | 1.8 | - | -8.17 |
2025-08-20 | DTIL | 4.67 | 1.8 | - | -8.17 |
2025-08-21 | DTIL | 4.73 | 1.8 | - | -8.17 |
2025-08-22 | DTIL | 4.97 | 1.8 | - | -8.17 |
2025-08-25 | DTIL | 5.09 | 1.8 | - | -8.17 |
2025-08-26 | DTIL | 5.04 | 1.8 | - | -8.17 |
2025-08-27 | DTIL | 5.04 | 1.8 | - | -8.17 |
2025-08-28 | DTIL | 5.01 | 1.8 | - | -8.17 |
2025-08-29 | DTIL | 4.90 | 1.8 | - | -8.17 |
2025-09-02 | DTIL | 5.00 | 1.8 | - | -8.17 |
2025-09-03 | DTIL | 5.00 | 1.8 | - | -8.17 |
2025-09-04 | DTIL | 5.00 | 1.8 | - | -8.17 |
2025-09-05 | DTIL | 5.07 | 1.8 | - | -8.17 |
2025-09-08 | DTIL | 4.97 | 1.8 | - | -8.17 |
2025-09-09 | DTIL | 5.12 | 1.8 | - | -8.17 |
2025-09-10 | DTIL | 5.02 | 1.8 | - | -8.17 |
2025-09-11 | DTIL | 5.00 | 1.8 | - | -8.17 |
2025-09-12 | DTIL | 4.64 | 1.8 | - | -8.17 |
Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
20 items
«
‹
Current Page1 of 1
›
»
20 items
«
‹
of 1
›
»
Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
---|---|---|---|---|
2025-08-15 | DTIL | 0.00 | 10.84 | 14.74 |
2025-08-18 | DTIL | 0.00 | -9.60 | 14.74 |
2025-08-19 | DTIL | 0.00 | -9.60 | 15.24 |
2025-08-20 | DTIL | 0.00 | -9.60 | 15.24 |
2025-08-21 | DTIL | 0.00 | -9.60 | 15.24 |
2025-08-22 | DTIL | 0.00 | -9.60 | 13.45 |
2025-08-25 | DTIL | 0.01 | 12.29 | 13.40 |
2025-08-26 | DTIL | 0.01 | 12.29 | 13.40 |
2025-08-27 | DTIL | 0.01 | 12.29 | 12.88 |
2025-08-28 | DTIL | 0.01 | 12.29 | 12.88 |
2025-08-29 | DTIL | 0.01 | 12.29 | 12.88 |
2025-09-02 | DTIL | 0.01 | 12.29 | 12.88 |
2025-09-03 | DTIL | 0.01 | 12.29 | 12.88 |
2025-09-04 | DTIL | 0.01 | 12.29 | 12.88 |
2025-09-05 | DTIL | 0.01 | 12.29 | 12.88 |
2025-09-08 | DTIL | 0.03 | 12.31 | 12.88 |
2025-09-09 | DTIL | 0.03 | 12.31 | 12.88 |
2025-09-10 | DTIL | 0.03 | 12.31 | 12.88 |
2025-09-11 | DTIL | 0.03 | 12.31 | 12.03 |
2025-09-12 | DTIL | 0.03 | 12.31 | 12.03 |
Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
20 items
«
‹
Current Page1 of 1
›
»
Last Quarter Act. EPS
-2.13
Avg. EPS Est. Current Quarter
-2.21
Avg. EPS Est. Next Quarter
-1.57
Insider Transactions
0.03
Institutional Transactions
12.31
Beta
1.69
Average Sales Estimate Current Quarter
5
Average Sales Estimate Next Quarter
5
Fair Value
Quality Score
14
Growth Score
31
Sentiment Score
33
Actual DrawDown %
99.1
Max Drawdown 5-Year %
-99.2
Target Price
30.5
P/E
Forward P/E
PEG
P/S
43.12
P/B
1.58
P/Free Cash Flow
EPS
-8.81
Average EPS Est. Cur. Y
-8.17
EPS Next Y. (Est.)
-6.68
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-6205.79
Relative Volume
1.39
Return on Equity vs Sector %
-254.7
Return on Equity vs Industry %
-241.5
EPS 1 7Days Diff
0.6
EPS 1 30Days Diff
0.57
EBIT Estimation
Sector: Healthcare
Industry: Biotechnology
Employees: 102
Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing therapies for gene edits, including gene insertion, excision, and elimination in the United States. The company offers ARCUS, a genome editing platform for DNA genome insertion, removal, and repair. It also provides PBGENE-HBV for the treatment of chronic hepatitis B virus (HBV) to eliminate covalently closed circular DNA with direct cuts and edits, as well as to inactivate integrated HBV DNA with the goal of long-lasting reductions in hepatitis B surface antigen; and PBGENE-3243 for the treatment of m.3243 associated mitochondrial myopathy. In addition, the company develops PBGENE-NVS (insertion) for sickle cell and beta thalassemia diseases; PBGENE-DMD (excision) for duchenne muscular dystrophy; PBGENE-LIVER (insertion), a liver directed target; PBGENE-CNS (excision), a central nervous system directed target; and iECURE-OTC (insertion) for ornithine transcarbamylase deficiency. It has collaboration agreements with Novartis Pharma AG to discover and develop in vivo gene editing products; TG Cell Therapy, Inc. to develop, manufacture, and commercialize azer-cel for autoimmune diseases and other indications outside of cancer; and iECURE, Inc. to develop ARCUS-based gene-insertion therapies. Precision BioSciences, Inc. was incorporated in 2006 and is headquartered in Durham, North Carolina.
stock quote shares DTIL – Precision BioSciences, Inc. Stock Price stock today
news today DTIL – Precision BioSciences, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch DTIL – Precision BioSciences, Inc. yahoo finance google finance
stock history DTIL – Precision BioSciences, Inc. invest stock market
stock prices DTIL premarket after hours
ticker DTIL fair value insiders trading